Sandler Laura Lee Insider Trades & Stock Holdings

Chief Operating Officer · Oruka Therapeutics, Inc. · Latest filing Jun 15, 2026

Sandler Laura Lee, Chief Operating Officer at Oruka Therapeutics, Inc. has 1 Form 4 trade on file since Jun 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($41.81K), net -$41.81K. Latest filing: disposed of 600 shares of $ORKA on Jun 15, 2026 at $69.69.

Trades on file

1

Open-market bought

$0

Open-market sold

$41.81K

Net open-market

-$41.81K

Latest filing

Jun 15, 2026

All insider trades by Sandler Laura Lee

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$ORKA	Sell (Open-market sale)	600	$69.69	$41.81K			+24.0%	+25.8%		Chief Operating Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Sandler Laura Lee traded

• $ORKA

Frequently asked questions

Has Sandler Laura Lee been buying or selling stock?

Sandler Laura Lee has 0 open-market purchases and 1 open-market sale on file, net -$41.81K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Sandler Laura Lee's latest insider trade?

disposed of 600 shares of $ORKA on Jun 15, 2026 at $69.69.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.